ADENYLOCRAT, created in 1957 (Germany), from 1125 sister brands and 17477 competing brands. The ADENYLOCRAT brand is owned by Pfizer Inc, a company listed in New York. ADENYLOCRAT belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(ADENYLOCRAT)
over 5 years*
USD 17.36